Findings from Part B and Part C of the DEVOTE study support the clinical benefits of a higher dose regimen...
TORONTO, ONTARIO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a...
Hello Heart selects Amwell platform to extend its reach across patient populationsBOSTON and MENLO PARK, Calif., Oct. 08, 2024 (GLOBE...
SEATTLE, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter...
Exclusively deploys Mestag’s proprietary RAFT platform to interrogate the pathogenic role of fibroblasts in inflammatory disease for novel target discoveryCAMBRIDGE,...
The Italian Medicines Agency AIFA and the Italian Ministry of Health have granted formal approval for NEUROBIS; a multi-centre Phase...
Prolia® (denosumab) is indicated to treat certain conditions that lead to high risk for fracture, including osteoporosis in postmenopausal womenTVB-009P,...
HOUSTON, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery...
Global study in approximately 180 adults with hidradenitis suppurativa to assess the efficacy and safety of two dose regimens of...
Diagonal is advancing its lead program to treat the underlying cause of hereditary hemorrhagic telangiectasia (HHT)WATERTOWN, Mass., Oct. 08, 2024...
LEXINGTON, Mass., Oct. 08, 2024 (GLOBE NEWSWIRE) -- KSQ Therapeutics, Inc. (KSQ), a clinical-stage biotechnology company developing novel treatments for...
TORONTO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (“VitalHub” or the “Company”) is pleased to...
Parisa Zamiri, MD, PhD, and Tom Reilly respectively appointed CMO and CFO Anand Sundaram appointed Vice President Marketing MELBOURNE, Australia...
Collaboration to help increase awareness of the power of genetic testing when it comes to learning about personal health risksSUNNYVALE,...
Renalytix plc American Depository Shares (ADSs) begin trading on OTCQB Venture Market under symbol “RNLXY” effective from Market Open on October...
Delivra is a unique consumer packaged goods company strategically positioned in the health and wellness sector that provides high-quality brands...
Two new trends: 'Anime & Friends' and 'Healthy Heroes'Perfect position: new central location at Eingang MitteNUREMBERG, Germany, Oct. 8, 2024 /PRNewswire/...
GOTHENBURG, SWEDEN / ACCESSWIRE / October 8, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company...
PALO ALTO, CA / ACCESSWIRE / October 8, 2024 / Bioz, Inc., a leader in AI-driven research solutions that drive...
Oakville, Ontario--(Newsfile Corp. - October 7, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or...